Literature DB >> 22306705

Characterization of circulating tumor cell aggregates identified in patients with epithelial tumors.

Edward H Cho1, Marco Wendel, Madelyn Luttgen, Craig Yoshioka, Dena Marrinucci, Daniel Lazar, Ethan Schram, Jorge Nieva, Lyudmila Bazhenova, Alison Morgan, Andrew H Ko, W Michael Korn, Anand Kolatkar, Kelly Bethel, Peter Kuhn.   

Abstract

Circulating tumor cells (CTCs) have been implicated as a population of cells that may seed metastasis and venous thromboembolism (VTE), two major causes of mortality in cancer patients. Thus far, existing CTC detection technologies have been unable to reproducibly detect CTC aggregates in order to address what contribution CTC aggregates may make to metastasis or VTE. We report here an enrichment-free immunofluorescence detection method that can reproducibly detect and enumerate homotypic CTC aggregates in patient samples. We identified CTC aggregates in 43% of 86 patient samples. The fraction of CTC aggregation was investigated in blood draws from 24 breast, 14 non-small cell lung, 18 pancreatic, 15 prostate stage IV cancer patients and 15 normal blood donors. Both single CTCs and CTC aggregates were measured to determine whether differences exist in the physical characteristics of these two populations. Cells contained in CTC aggregates had less area and length, on average, than single CTCs. Nuclear to cytoplasmic ratios between single CTCs and CTC aggregates were similar. This detection method may assist future studies in determining which population of cells is more physically likely to contribute to metastasis and VTE.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22306705      PMCID: PMC3387999          DOI: 10.1088/1478-3975/9/1/016001

Source DB:  PubMed          Journal:  Phys Biol        ISSN: 1478-3967            Impact factor:   2.583


  10 in total

1.  Isolation of circulating tumor cells using a microvortex-generating herringbone-chip.

Authors:  Shannon L Stott; Chia-Hsien Hsu; Dina I Tsukrov; Min Yu; David T Miyamoto; Belinda A Waltman; S Michael Rothenberg; Ajay M Shah; Malgorzata E Smas; George K Korir; Frederick P Floyd; Anna J Gilman; Jenna B Lord; Daniel Winokur; Simeon Springer; Daniel Irimia; Sunitha Nagrath; Lecia V Sequist; Richard J Lee; Kurt J Isselbacher; Shyamala Maheswaran; Daniel A Haber; Mehmet Toner
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-07       Impact factor: 11.205

2.  Promotion of experimental thrombus formation by the procoagulant activity of breast cancer cells.

Authors:  M A Berny-Lang; J E Aslan; G W Tormoen; I A Patel; P E Bock; A Gruber; O J T McCarty
Journal:  Phys Biol       Date:  2011-02-07       Impact factor: 2.583

3.  Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy.

Authors:  A A Khorana; C W Francis; E Culakova; N M Kuderer; G H Lyman
Journal:  J Thromb Haemost       Date:  2007-03       Impact factor: 5.824

4.  Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium.

Authors:  Vladislav V Glinsky; Gennadi V Glinsky; Olga V Glinskii; Virginia H Huxley; James R Turk; Valeri V Mossine; Susan L Deutscher; Kenneth J Pienta; Thomas P Quinn
Journal:  Cancer Res       Date:  2003-07-01       Impact factor: 12.701

5.  Cytomorphology of circulating colorectal tumor cells:a small case series.

Authors:  Dena Marrinucci; Kelly Bethel; Daniel Lazar; Jennifer Fisher; Edward Huynh; Peter Clark; Richard Bruce; Jorge Nieva; Peter Kuhn
Journal:  J Oncol       Date:  2010-01-06       Impact factor: 4.375

6.  Expression of E-cadherin, Snail and Hakai in epithelial cells isolated from the primary tumor and from peritumoral tissue of invasive ductal breast carcinomas.

Authors:  F B A Makdissi; L V S T Machado; A G C Oliveira; T T Benvenuti; M L H Katayama; M M Brentani; C A B T Osório; M Mourão Netto; E C Lyra; F Carvalho; J C S Góes; M A A K Folgueira
Journal:  Braz J Med Biol Res       Date:  2009-11-06       Impact factor: 2.590

7.  Circulating tumour tissue fragments in patients with pulmonary metastasis of clear cell renal cell carcinoma.

Authors:  Gursah Kats-Ugurlu; Ilse Roodink; Mirjam de Weijert; Dorien Tiemessen; Cathy Maass; Kiek Verrijp; Jeroen van der Laak; Rob de Waal; Peter Mulders; Egbert Oosterwijk; William Leenders
Journal:  J Pathol       Date:  2009-11       Impact factor: 7.996

Review 8.  Cadherin switch in tumor progression.

Authors:  Rachel B Hazan; Rui Qiao; Rinat Keren; Ines Badano; Kimita Suyama
Journal:  Ann N Y Acad Sci       Date:  2004-04       Impact factor: 5.691

Review 9.  Epithelial--mesenchymal and mesenchymal--epithelial transitions in carcinoma progression.

Authors:  Honor Hugo; M Leigh Ackland; Tony Blick; Mitchell G Lawrence; Judith A Clements; Elizabeth D Williams; Erik W Thompson
Journal:  J Cell Physiol       Date:  2007-11       Impact factor: 6.384

10.  Circulating tumor cells from well-differentiated lung adenocarcinoma retain cytomorphologic features of primary tumor type.

Authors:  Dena Marrinucci; Kelly Bethel; Madelyn Luttgen; Richard H Bruce; Jorge Nieva; Peter Kuhn
Journal:  Arch Pathol Lab Med       Date:  2009-09       Impact factor: 5.534

  10 in total
  88 in total

Review 1.  Clinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer.

Authors:  Francesca Riva; Oleksii I Dronov; Dmytro I Khomenko; Florence Huguet; Christophe Louvet; Pascale Mariani; Marc-Henri Stern; Olivier Lantz; Charlotte Proudhon; Jean-Yves Pierga; Francois-Clement Bidard
Journal:  Mol Oncol       Date:  2016-01-22       Impact factor: 6.603

2.  Circulating tumor microemboli diagnostics for patients with non-small-cell lung cancer.

Authors:  Anders Carlsson; Viswam S Nair; Madelyn S Luttgen; Khun Visith Keu; George Horng; Minal Vasanawala; Anand Kolatkar; Mehran Jamali; Andrei H Iagaru; Ware Kuschner; Billy W Loo; Joseph B Shrager; Kelly Bethel; Carl K Hoh; Lyudmila Bazhenova; Jorge Nieva; Peter Kuhn; Sanjiv S Gambhir
Journal:  J Thorac Oncol       Date:  2014-08       Impact factor: 15.609

3.  Fluid phase biopsy for detection and characterization of circulating endothelial cells in myocardial infarction.

Authors:  Kelly Bethel; Madelyn S Luttgen; Samir Damani; Anand Kolatkar; Rachelle Lamy; Mohsen Sabouri-Ghomi; Sarah Topol; Eric J Topol; Peter Kuhn
Journal:  Phys Biol       Date:  2014-01-09       Impact factor: 2.583

4.  Cellular Expression of PD-L1 in the Peripheral Blood of Lung Cancer Patients is Associated with Worse Survival.

Authors:  Daniel J Boffa; Ryon P Graf; Michelle C Salazar; Jessica Hoag; David Lu; Rachel Krupa; Jessica Louw; Lyndsey Dugan; Yipeng Wang; Mark Landers; Mahipal Suraneni; Stephanie B Greene; Marisa Magaña; Samir Makani; Lyudmila Bazhenova; Ryan V Dittamore; Jorge Nieva
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-04-26       Impact factor: 4.254

5.  Circulating Tumor Cells: When a Solid Tumor Meets a Fluid Microenvironment.

Authors:  Katarzyna A Rejniak
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

6.  Circulating tumor cells as emerging tumor biomarkers in lung cancer.

Authors:  Edward H Cho
Journal:  J Thorac Dis       Date:  2012-10       Impact factor: 2.895

Review 7.  Phenotype of circulating tumor cell: face-off between epithelial and mesenchymal masks.

Authors:  Yupeng Hong; Qi Zhang
Journal:  Tumour Biol       Date:  2016-01-13

8.  Circulating tumor cells in prostate cancer diagnosis and monitoring: an appraisal of clinical potential.

Authors:  Giuseppe Galletti; Luigi Portella; Scott T Tagawa; Brian J Kirby; Paraskevi Giannakakou; David M Nanus
Journal:  Mol Diagn Ther       Date:  2014-08       Impact factor: 4.074

Review 9.  Blood-based analyses of cancer: circulating tumor cells and circulating tumor DNA.

Authors:  Daniel A Haber; Victor E Velculescu
Journal:  Cancer Discov       Date:  2014-05-06       Impact factor: 39.397

Review 10.  Biophysical technologies for understanding circulating tumor cell biology and metastasis.

Authors:  Derrick W Su; Jorge Nieva
Journal:  Transl Lung Cancer Res       Date:  2017-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.